Issam I. Raad, Distinguished Professor

Professor
MD Anderson UT

Disclosure(s): Citius Pharmaceuticals, Inc. (Grant/Research Support): Advisor/Consultant, Grant/Research Support, Ownership Interest, Patent, Stocks/Bonds (Public Company); Spectrum Vascular: Ownership Interest, Patent

Poster(s):

• (P-101) A Phase 3 International, Multi-Center, Randomized, Open-Label, Assessor-Blind Study to Evaluate the Efficacy and Safety of Minocycline/EDTA/Ethanol (Mino-Lok) Therapy (MLT) vs Site-Specific Antimicrobial Lock in Combination with Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1051) Antibiotic Elution Patterns Correlate with Antibacterial Activity of Three Antibiotic Antimicrobial Central Venous Catheters (CVCs)
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1052) Impact of Chlorhexidine Elution Profiles on Antifungal Durability of Two Chlorhexidine-Coated Antimicrobial Central Venous Catheters (CVCs)
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1178) Antibacterial Activity of a Polygalacturonic and Caprylic Acid Wound Ointment Compared with Hypochlorous Acid Against Polymicrobial Biofilms in a Three-Dimensional Wound Biofilm Model
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET